Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction

Chan JIANG; Xi WANG; Song DANG; Xin WANG; Qing DENG; Juan HU; Cong-xin HUANG

doi:10.1007/s11655-018-2578-1

Your Location：

Home >

Browse articles >

Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction

Original Article | Updated：2021-08-16

- Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction
- Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction
- Chinese Journal of Integrative Medicine 2021年27卷第1期页码：24-30
- Affiliations：
  
  1.Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan (430061), China
  2.Cardiovascular Research Institute of Wuhan University, Wuhan (430061), China
- Author bio：
  
  Correspondence to: Dr. WANG Xi, E-mail: xiwangwhu@163.com
- Funds：
  
  the National Key Basic Research Development Program of China (The "973" Program)
- DOI：10.1007/s11655-018-2578-1
  中图分类号：
- 纸质出版日期：2021-01-01，
  
  网络出版日期：2019-01-09，
  
  录用日期：2017-10-09
Scan for full text
Chan JIANG, Xi WANG, Song DANG, 等. Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction[J]. Chinese Journal of Integrative Medicine, 2021,27(1):24-30.

Chan JIANG, Xi WANG, Song DANG, et al. Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction[J]. Chinese Journal of Integrative Medicine, 2021,27(1):24-30.
Chan JIANG, Xi WANG, Song DANG, 等. Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction[J]. Chinese Journal of Integrative Medicine, 2021,27(1):24-30. DOI： 10.1007/s11655-018-2578-1.

Chan JIANG, Xi WANG, Song DANG, et al. Chinese Medicine Shensong Yangxin Capsule (参松养心胶囊)Ameliorates Myocardial Microcirculation Dysfunction in Rabbits with Chronic Myocardial Infarction[J]. Chinese Journal of Integrative Medicine, 2021,27(1):24-30. DOI： 10.1007/s11655-018-2578-1.

摘要

Abstract

Objective:

To investigate the effect of Chinese compound Shensong Yangxin Capsule (参松养心胶囊

SSYX) on myocardial microcirculation in myocardial-infarcted rabbits.

Methods:

Myocardial infarction (MI) was established in rabbits by ligation of the left circumflex coronary. Thirty rabbits were randomly divided into the control group

the MI group (model)

and the MI treated with SSYX group (MI+SSYX) by a random number table method. After 4 weeks of administration

low-energy real-time myocardial contrast echocardiography (RT-MCE) was conducted to assess the microcirculatory perfusion. Immunofluorescence double staining was used to detect the capillary density. The endothelial ultrastructure was observed with a transmission electron microscope. The mRNA expression levels of vascular endothelial growth factor (VEGF)

endothelin 1 (ET-1)

prostaglandin I2 (PGI2) and endothelial nitric oxide synthase (eNOS) were measured by real-time quantitative polymerase chain reaction (Real-time PCR). The plasmic levels of ET-1

thromboxane A2 (TXA2)

nitric oxide (NO) and von willebrand factor (vWF) were examined with enzyme-linked immunosorbent assays (ELISA).

Results:

SSYX significantly improved the myocardial blood volume

myocardial micro bubble velocity

and myocardial inflow according to the examination of RT-MCE

and it visibly ameliorated the capillary endothelial structure. Furthermore

compared with the MI group

the plasma levels of TXA2

ET-1 and vWF contents significantly decreased in the MI+SSYX group

and the ET-1 mRNA expression levels of myocardium in the border zone significantly decreased

and the VEGF

PGI2 and eNOS mRNA expression levels significantly increased (all

0.05).

Conclusions:

SSYX has favorable advantages in ameliorating the impaired myocardial microcirculation following MI. The mechanisms of the effect are related to the ability of SSYX in balancing the endothelial-derived vasodilators and vasoconstrictors

and up-regulating the expression of VEGF and eNOS.

关键词

Keywords

myocardial infarctionmicrocirculationendotheliumangiogenesisShensong Yangxin Capsule

references

Heinonen I, Sorop O, de Beer VJ, Duncker DJ, Merkus D. What can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculation. J Appl Physiol 2015;119:934-943.

Laughlin MH, Davis MJ, Secher NH, van Lieshout JJ, Arce-Esquivel AA, Simmons GH, et al. Peripheral circulation.Compr Physiol 2012;2:321-447.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P,Stebbins A, Kim RJ, et al. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: an assessment of pexelizumab in acute myocardial infarction (APEX-AMI) substudy. Am Heart J 2010;160:272-278.

Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO,Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC: Cardiovasc Interv 2015;8:1445-1453.

Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003;108:2911-2917.

Fischer-Rasokat U, Spyridopoulos I, Walter J, Honold J, Zeiher AM, Fichtlscherer S. Microvascular dysfunction and pulse wave reflection characterize different vascular pathologies in patients at cardiovascular risk. Vasa 2012;41:192-199.

Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality.Eur Heart J 2012;33:2771-2782.

van de Hoef TP, Bax M, Meuwissen M, Damman P, Delewi R, de Winter RJ, et al. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2013;6:207-215.

Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality.Eur Heart J 2012;33:2771-2782.

Liu Y, Li N, Jia Z, Lu F, Pu J. Chinese medicine Shensong Yangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial.Evid Based Complement Alternat Med 2014;2014:605714.

Liu M, Zhao S, Wang Y, Liu T, Li S, Wang H, et al.Identification of multiple constituents in Chinese medicinal prescription Shensong Yangxin Capsule by ultra-fast liquid chromatography combined with quadrupole time-of-flight mass spectrometry. J Chromatogr Sci 2015;53:240-252.

Wu Y. Construction of the vessel-collateral theory and its guidance for prevention and treatment of vasculopathy.Front Med 2011;5:118-122.

Liu M, Li S, Zhao S, Wang H, Wang H, Tu P. Studies on excretion kinetics of ten constituents in rat urine after oral administration of Shensong Yangxin Capsule by UPLC-MS/MS. Biomed Chromatogr 2014;28:525-533.

Wang J, Li J, Feng B. Shensong Yangxin Capsule combined with antiarrhythmic drugs, a new integrative medicine therapy,for the treatment of frequent premature ventricular contractions(FPVC): a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2014;2014:976713.

Qu Z, Xu H, Tian Y, Jiang X. Atorvastatin improves microenvironment to enhance the beneficial effects of BMSCs therapy in a rabbit model of acute myocardial infarction. Cell Physiol Biochem 2013;32:380-389.

Li DY, Hao J, Xia Y, Zhang H, Xu TD, Wang XP, et al.Clinical usefulness of low-dose dobutamine stress real-time myocardial contrast echocardiography for detection of viable myocardium. J Clin Ultrasound 2012;40:272-279.

Falcao SN, Rochitte CE, Junior WM, Quaglia L, Lemos PA,Sbano JC, et al. Incremental value of perfusion over wall-motion abnormalities with the use of dobutamine-atropine stress myocardial contrast echocardiography and magnetic resonance imaging for detecting coronary artery disease.Echocardiography 2013;30:45-54.

Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 2014;7:940-952.

Cicco G, Cicco S. The influence of oxygen supply,hemorheology and microcirculation in the heart and vascular systems. Adv Exp Med Biol 2010;662:33-39.

Loiola RA, Torres TC, Aburaya CM, Landgraf MA, Landgraf RG, Bosco PJ, et al. Generation and characterization of a spontaneously immortalized endothelial cell line from mice microcirculation. Exp Cell Res 2013;319:1102-1110.

Smith JB, Araki H, Lefer AM. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation 1980;62:19-25.

Couto GK, Britto LR, Mill JG, Rossoni LV. Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction. J Mol Cell Cardiol 2015;86:110-120.

Thengchaisri N, Hein TW, Ren Y, Kuo L. Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase. J Mol Cell Cardiol 2015;86:75-84.

DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, et al. Thromboxane A(2) generation, in the absence of platelet COX-1 activity,in patients with and without atherothrombotic myocardial infarction. Circ J 2013;77:2786-2792.

Duncker DJ, Merkus D. Regulation of coronary blood flow.Effect of coronary artery stenosis. Arch Mal Coeur Vaiss 2004;97:1244-1250.

Tousoulis D, Simopoulou C, Papageorgiou N, Oikonomou E, Hatzis G, Siasos G, et al. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches. Pharmacol Ther 2014;144:253-267.

Scridon A, Girerd N, Rugeri L, Nonin-Babary E, Chevalier P.Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace 2013;15:1562-1566.

Dashkevich A, Hagl C, Beyersdorf F, Nykanen AI,Lemstrom KB. VEGF Pathways in the Lymphatics of Healthy and Diseased Heart. Microcirculation 2016;23:5-14.

Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006;312:549-560.

Pan WK, Li P, Guo ZT, Huang Q, Gao Y. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. Pediatr Blood Cancer 2015;62:1414-1420.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NFκB Pathway

Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial

Effect of Chinese Medicine on No or Slow Reflow after Percutaneous Coronary Intervention in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis

Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on Angiogenesis in Hindlimb Ischemic Rats

Garlicin Post-conditioning Suppresses Adhesion Molecules in Porcine Model of Myocardial Ischemia-Reperfusion Injury